Canada Pension Plan Investment Board
IPXL

Canada Pension Plan Investment Board’s Impax Laboratories, Inc. IPXL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-45,000
Closed -$913K – 1256
2017
Q3 		$913K Sell
45,000
-221,688
-83% -$4.24M ﹤0.01% 953
2017
Q2 		$4.29M Sell
266,688
-214,512
-45% -$3.17M 0.01% 675
2017
Q1 		$6.09M Buy
481,200
+34,700
+8% +$419K 0.02% 574
2016
Q4 		$5.92M Buy
446,500
+319,200
+251% +$5.46M 0.02% 483
2016
Q3 		$3.02M Buy
+127,300
New +$3.42M 0.01% 626

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board's IPXL Position: Q4 2017 in Review

Canada Pension Plan Investment Board sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 45,000 shares — an estimated $913K sold.

Canada Pension Plan Investment Board first reported a position in IPXL in Q3 2016 and held it in 5 quarters. The position peaked at $6.09M in Q1 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Canada Pension Plan Investment Board reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 45,000 Impax Laboratories, Inc. shares in Q4 2017, an estimated $913K.
  • Canada Pension Plan Investment Board first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's Impax Laboratories, Inc. position peaked at $6.09M in Q1 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2017, filed 14 Feb 2018.